OSDI Outcomes Based on Patient Demographic and Wear Patterns in Prosthetic Replacement of the Ocular Surface Ecosystem

References

• Chiu GB, Bach D, Theophanous C, Heur M. Prosthetic replacement of the ocular surface ecosystem (PROSE) scleral lens for Salzmann’s nodular degeneration. Saudi J Ophthalmol. 2014;28(3):203–206. doi:10.1016/j.sjopt.2014.06.001
   PubMedGoogle Scholar
• Heur M, Bach D, Theophanous C, Chiu GB. Prosthetic replacement of the ocular surface ecosystem scleral lens therapy for patients with ocular symptoms of chronic Stevens-Johnson syndrome. Am J Ophthalmol. 2014;158(1):49–54. doi:10.1016/j.ajo.2014.03.012
   PubMed Web of Science ®Google Scholar
• Chahal JS, Heur M, Chiu GB. Prosthetic replacement of the ocular surface ecosystem scleral lens therapy for exposure keratopathy. Eye Contact Lens. 2017;43(4):240–244. doi:10.1097/ICL.0000000000000265
   PubMed Web of Science ®Google Scholar
• Dimit R, Gire A, Pflugfelder SC, Bergmanson JPG. Patient ocular conditions and clinical outcomes using a PROSE scleral device. Contact Lens Anterior Eye. 2013;36(4):159–163. doi:10.1016/j.clae.2013.02.004
   PubMed Web of Science ®Google Scholar
• Theophanous C, Irvine JA, Parker P, Chiu GB. Use of prosthetic replacement of the ocular surface ecosystem scleral lenses in patients with ocular chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2015;21(12):2180–2184. doi:10.1016/j.bbmt.2015.07.027
   PubMed Web of Science ®Google Scholar
• Segal O, Barkana Y, Hourovitz D, et al. Scleral contact lenses may help where other modalities fail. Cornea. 2003;22(4):308–310. doi:10.1097/00003226-200305000-00006
   PubMed Web of Science ®Google Scholar
• La Porta Weber S, Becco De Souza R, Gomes JÁP, Hofling-Lima AL. The use of the esclera scleral contact lens in the treatment of moderate to severe dry eye disease. Am J Ophthalmol. 2016;163:167–173.e1. doi:10.1016/j.ajo.2015.11.034
   PubMed Web of Science ®Google Scholar
• Schornack MM. Scleral lenses: a literature review. Eye Contact Lens. 2015;41:3–11. doi:10.1097/ICL.0000000000000083
   PubMed Web of Science ®Google Scholar
• Baran I, Bradley JA, Alipour F, Rosenthal P, Le HG, Jacobs DS. PROSE treatment of corneal ectasia. Contact Lens Anterior Eye. 2012;35:222–227. doi:10.1016/j.clae.2012.04.003
   PubMed Web of Science ®Google Scholar
• Bhattacharya P, Mahadevan R. Quality of life and handling experience with the PROSE device: an Indian scenario. Clin Exp Optom. 2017;100(6):710–717. doi:10.1111/cxo.12519
   PubMed Web of Science ®Google Scholar
• Friedman NJ. Impact of dry eye disease and treatment on quality of life. Curr Opin Ophthalmol. 2010;21:310–316. doi:10.1097/ICU.0b013e32833a8c15
   PubMed Web of Science ®Google Scholar
• Miller KL, Walt JG, Mink DR, et al. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol. 2010;128:94. doi:10.1001/archophthalmol.2009.356
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G, Sumner W. Utility assessment among patients with dry eye disease. Ophthalmology. 2003;110:1412–1419. doi:10.1016/S0161-6420(03)00462-7
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118(5):615–621. doi:10.1001/archopht.118.5.615
   PubMedGoogle Scholar
• Walt JG, Rowe SK. Evaluating the functional impact of dry eye: the Ocular Surface Disease Index. Drug Inf J. 1997;31:b5.
   Google Scholar
• Bottomley A, Jones D, Claassens L. Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. Eur J Cancer. 2009;45:347–353. doi:10.1016/j.ejca.2008.09.032
   PubMed Web of Science ®Google Scholar
• Laad S, Singh H, Singh S, et al. Magnitude of dry eye among medical students and its impact on their mental health: a questionnaire based survey. J Evid Based Med Healthc. 2019;6(35):2393–2396. doi:10.18410/jebmh/2019/489
   Google Scholar
• Keogh E, Cochrane M. Anxiety sensitivity, cognitive biases, and the experience of pain. J Pain. 2002;3:320–329. doi:10.1054/jpai.2002.125182
   PubMed Web of Science ®Google Scholar
• Szakáts I, Sebestyén M, Németh J, Birkás E, Purebl G. The role of health anxiety and depressive symptoms in dry eye disease. Curr Eye Res. 2016;41(8):1044–1049. doi:10.3109/02713683.2015.1088955
   PubMed Web of Science ®Google Scholar
• Kim KW, Han SB, Han ER, et al. Association between depression and dry eye disease in an elderly population. Investig Ophthalmol Vis Sci. 2011;52:7954. doi:10.1167/iovs.11-8050
   PubMed Web of Science ®Google Scholar
• Galor A, Feuer W, Lee DJ, et al. Depression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the National United States veterans affairs administrative database. Am J Ophthalmol. 2012;154:340–346.e2. doi:10.1016/j.ajo.2012.02.009
   PubMed Web of Science ®Google Scholar
• Klauenberg S, Maier C, Assion HJ, et al. Depression and changed pain perception: hints for a central disinhibition mechanism. Pain. 2008;140:332–343. doi:10.1016/j.pain.2008.09.003
   PubMed Web of Science ®Google Scholar
• Siedlecki AN, Smith SD, Siedlecki AR, Hayek SM, Sayegh RR. Ocular pain response to treatment in dry eye patients: ocular pain treatment response. Ocul Surf. 2020;18(2):305–311. doi:10.1016/j.jtos.2019.12.004
   PubMed Web of Science ®Google Scholar
• He X, Donaldson KE, Perez VL, Sotomayor P. Case series: overnight wear of scleral lens for persistent epithelial defects. Optom Vis Sci. 2018;95:70–75. doi:10.1097/OPX.0000000000001162
   PubMed Web of Science ®Google Scholar
• Lim P, Ridges R, Jacobs DS, Rosenthal P. Treatment of persistent corneal epithelial defect with overnight wear of a prosthetic device for the ocular surface. Am J Ophthalmol. 2013;156:1095–1101. doi:10.1016/j.ajo.2013.06.006
   PubMed Web of Science ®Google Scholar
• Rosenthal P, Cotter J. The Boston scleral lens in the management of severe ocular surface disease. Ophthalmol Clin North Am. 2003;16:89–93. doi:10.1016/S0896-1549(02)00067-6
   PubMedGoogle Scholar
• Gungor I, Schor K, Rosenthal P, Jacobs DS. The Boston Scleral Lens in the treatment of pediatric patients. J AAPOS. 2008;12:263–267. doi:10.1016/j.jaapos.2007.11.008
   PubMed Web of Science ®Google Scholar
• Kamal SM, Riccobono K, Kwok A, Edmond JC, Pflugfelder SC. Unilateral pediatric neurotrophic keratitis due to congenital left trigeminal nerve aplasia with PROSE (prosthetic replacement of the ocular surface ecosystem) treatment. Am J Ophthalmol Case Rep. 2020;20. doi:10.1016/j.ajoc.2020.100854
   PubMedGoogle Scholar
• Wang Y, Rao R, Jacobs DS, Saeed HN. Prosthetic replacement of the ocular surface ecosystem treatment for ocular surface disease in pediatric patients with Stevens-Johnson syndrome. Am J Ophthalmol. 2019;201:1–8. doi:10.1016/j.ajo.2019.01.006
   PubMed Web of Science ®Google Scholar
• Remington CD, Jacobs DS. PROSE treatment for pediatric patients with neurotrophic keratitis. Investig Ophthalmol Vis Sci. 2015;56(7):6076.
   PubMed Web of Science ®Google Scholar
• Rosenthal P, Croteau A. Fluid-ventilated, gas-permeable scleral contact lens is an effective option for managing severe ocular surface disease and many corneal disorders that would otherwise require penetrating keratoplasty. Eye Contact Lens. 2005;31:130–134. doi:10.1097/01.ICL.0000152492.98553.8D
   PubMedGoogle Scholar
• Craig JP, Nelson JD, Azar DT, et al. TFOS DEWS II report executive summary. Ocul Surf. 2017;15(4). doi:10.1016/j.jtos.2017.08.003
   Web of Science ®Google Scholar
• Moon J, Lee SM, Hyon JY, Kim MK, Oh JY, Choi HJ. Large diameter scleral lens benefits for Asians with intractable ocular surface diseases: a prospective, single-arm clinical trial. Sci Rep. 2021;11(1):1–11. doi:10.1038/s41598-021-82010-z
   PubMed Web of Science ®Google Scholar
• Harthan J, Nau CB, Barr J, et al. Scleral lens prescription and management practices: the scope study. Eye Contact Lens. 2018;44:S228–S232. doi:10.1097/ICL.0000000000000387
   PubMed Web of Science ®Google Scholar
• Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15(3). doi:10.1016/j.jtos.2017.05.006
   Web of Science ®Google Scholar
• Li J, Zhang X, Zheng Q, et al. Comparative evaluation of silicone hydrogel contact lenses and autologous serum for management of Sjögren syndrome-associated dry eye. Cornea. 2015;34(9):1072–1078. doi:10.1097/ICO.0000000000000515
   PubMed Web of Science ®Google Scholar
• Scanzera AC, Bontu S, Joslin CE, McMahon T, Rosenblatt M, Shorter E. Prevalence of ocular surface disease and corneal irregularity and outcomes in patients using therapeutic scleral lenses at a tertiary care center. Eye Contact Lens. 2020;46(6):364–367. doi:10.1097/ICL.0000000000000679
   PubMed Web of Science ®Google Scholar
• Barnett M, Courey C, Fadel D, et al. CLEAR - Scleral lenses. Contact Lens Anterior Eye. 2021;44(2):270–288. doi:10.1016/j.clae.2021.02.001
   PubMed Web of Science ®Google Scholar
• Yılmaz U, Küçük E, Koç Ç, Gökler E. Comparison of autologous serum versus preservative free artificial tear in patients with dry eyes due to systemic isotretinoin therapy. Curr Eye Res. 2017;42(6):827–831. doi:10.1080/02713683.2016.1255758
   PubMed Web of Science ®Google Scholar
• Latifi G, Banafshe Afshan A, Houshang Beheshtnejad A, et al. Changes in corneal subbasal nerves after punctal occlusion in dry eye disease. Curr Eye Res. 2020;1–7. doi:10.1080/02713683.2020.1833349
   Web of Science ®Google Scholar
• Yüksel B, Bozdaǧ B, Acar M, Topaloǧlu E. Evaluation of the effect of topical cyclosporine A with impression cytology in dry eye patients. Eur J Ophthalmol. 2010;20(4):675–679. doi:10.1177/112067211002000405
   PubMed Web of Science ®Google Scholar
• Sheppard JD, Donnenfeld ED, Holland EJ, et al. Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%. Eye Contact Lens. 2014;40(5):289–296. doi:10.1097/ICL.0000000000000049
   PubMed Web of Science ®Google Scholar
• Finis D, Hayajneh J, König C, Borrelli M, Schrader S, Geerling G. Evaluation of an automated thermodynamic treatment (Lipiflow®) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial. Ocul Surf. 2014;12(2):146–154. doi:10.1016/j.jtos.2013.12.001
   PubMed Web of Science ®Google Scholar
• Napoli PE, Nioi M, d’Aloja E, Fossarello M. The bull’s eye pattern of the tear film in humans during visual fixation on en-face optical coherence tomography. Sci Rep. 2019;9(1). doi:10.1038/s41598-018-38260-5
   Web of Science ®Google Scholar
• Napoli PE, Coronella F, Satta GM, Fossarello M, Aegerter C. A novel technique of contrast-enhanced optical coherence tomography imaging in evaluation of clearance of lipids in human tears. PLoS One. 2014;9(11):e109843. doi:10.1371/journal.pone.0109843
   PubMed Web of Science ®Google Scholar
• Napoli PE, Coronella F, Satta GM, et al. Evaluation of the adhesive properties of the cornea by means of optical coherence tomography in patients with meibomian gland dysfunction and lacrimal tear deficiency. PLoS One. 2014;9(12):e115762. doi:10.1371/journal.pone.0115762
   PubMed Web of Science ®Google Scholar